95% of Eligible Patients Never Join a Trial — and AI Just Killed the Excuse

Episode 48

0:00-45:14

Lisa Kerr on why 95% of eligible patients never join a clinical trial | Pharma Prescribed Lisa Kerr is Head of Patient Engagement at Evinova, AstraZeneca's health tech business — a PhD chemist who climbed to global project director, hit a cliff edge, and came back with a mission. In this episode Lisa talks openly about the divorce, the clinical depression, and the three months as an outpatient at the Priory that reshaped her career. She founded AstraZeneca's Safe Space employee resource group after one Workplace post she thought would end her career — and built mental health navigation tools that scaled globally. She then turns that lived experience on the industry itself: only 5–7% of eligible patients ever join a clinical trial, and that number has barely moved in a decade despite digitisation and healthcare transformation. Lisa explains the EACH framework, why patients are the real investors in a trial (time, health, trust — given for free), and why AI has just destroyed pharma's last excuse for not designing trials with patients. Honest, funny, and unusually direct. No soundbites, no spin.

Publisher

Adam Walker’s Pharma Prescribed Podcast

Link

pharmaprescribed.podbean.com/e/lisa-kerr-on-why-95-of-eligible-patients-never-join-a-clinical-trial-pharma-prescribed/

Published

July 13, 2026

Duration

45 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Adam Walker

AW

Adam Walker’s Pharma Prescribed Podcast

@adamwalkerspharmaprescribedp

#eligiblepatients #killed #excuse #lifesciences #management

The Nile